Friday, January 30, 2026

AI Optimization Just Got a 5X Upgrade—And a $4.5M Endorsement

TheStage AI secures $4.5M funding to enhance AI model optimization, aiming to reduce GPU reliance and improve performance significantly.

Russia Contacts South Korea Following North Korean Troop Withdrawal As Normalization Of Relations Nears Amid Speculation Of Post-War Shifts

Russia's informal talks with South Korea on North Korean issues reflect diplomatic sensitivity amid strained relations with Pyongyang.

Big Bang Reunion at MAMA? G-Dragon, Taeyang, and Daesung Prepare for a Historic Performance

G-Dragon returns to the MAMA stage after a long hiatus, reuniting with Taeyang and Daesung for a highly anticipated performance.

Tag: development

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationschina

How AI is Revolutionizing Coding: 30% of Code Now Generated by AI!

AI is rapidly replacing human programmers in coding, with significant productivity gains and changing job demands in the tech industry.

Eli Lilly vs. Novo Nordisk: A $1.2 Billion Bet Reveals Two Very Different Futures for Obesity Drugs

Eli Lilly and Novo Nordisk are pursuing different strategies in the obesity treatment market, focusing on expansion versus core strengths.

Why Ebola Now? SK Bioscience Joins a $30 Million Global Push to Rethink Ebola Vaccine Production

SK Bioscience secures funding to enhance Ebola vaccine production, improving yield and stability for better accessibility amid outbreaks.

Unlocking the Future: How Neuracle Science’s NS101 is Set to Revolutionize Alzheimer’s Treatment by 2030

Neuracle Science aims for a KOSDAQ listing and focuses on developing NS101 for neurological diseases, attracting global interest.

Unlocking the Future of Health Supplements: HLB Global and Nodcure’s Game-Changing Partnership

HLB Global partners with Nodcure for joint development of next-gen health supplements, aiming to innovate and expand market reach.

How SK Bioscience Plans to Dominate the Global Vaccine Market in 2026

SK Bioscience enhances its operational system with new COO and key appointments to boost global competitiveness and vaccine development.

Revolutionizing Pharma: How LG CNS’s Agentic AI is Set to Transform Drug Development in South Korea

LG CNS expands its AI Transformation business into pharma, enhancing drug development with AI-driven platforms and automation services.

From Hair Loss to Inflammation: JW Pharmaceutical Showcases Pipeline to Global Pharma at JPMorgan

JW Pharmaceutical participated in the JP Morgan Healthcare Conference, discussing potential drug partnerships and licensing deals.

GI Innovation Uses AI to Develop Next-Gen Allergy Drug Aimed at Dupixent’s $15 Billion Market

GI Innovation is advancing an AI-optimized allergy treatment, targeting multiple pathways in atopic dermatitis to rival Dupixent.

Is DD01 the Future of MASH Treatment? Insights from D&D Pharmatech’s JP Morgan Presentation

D&D Pharmatech's CEO highlights growth in K-bio at JPM Healthcare Conference, unveiling promising drug data and future plans for clinical trials.

Nvidia and Eli Lilly: How AI is Revolutionizing Drug Development in 2026

Nvidia partners with Eli Lilly to enhance AI in drug development, aiming to revolutionize the biotech industry.

How Celltrion Plans to Expand Its Biosimilar Portfolio to 41 Products by 2038

Celltrion unveils its growth strategy at the JP Morgan Healthcare Conference, aiming to expand biosimilars and develop new drug pipelines.

2026: South Korea’s Advanced Regenerative Medicine R&D Investment Expands – What You Need to Know!

The Ministry of Health and Welfare aims to boost investments in advanced regenerative medicine R&D and improve research infrastructure in South Korea.

Revolutionizing Drug Development: Ewha Womans University Partners with Cureverse for AI-Powered Innovations

Ewha Womans University and Cureverse Inc. partner for AI-driven drug development, focusing on collaboration and expert training.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.